Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq®, in Kenya, including among HIV-infected and HIV-exposed infants
Kayla F. Laserson, Daveline Nyakundi, Daniel R. Feikin, Geoffrey Nyambane, Earnest Cook, Janet Oyieko, Joel Ojwando, Stephen B. Rivers, Max Ciarlet, Kathleen M. Neuzil, Robert F. BreimanVolume:
30
Year:
2012
Language:
english
DOI:
10.1016/j.vaccine.2011.09.026
File:
PDF, 470 KB
english, 2012